SpaceX, the Force-Fed Valuation, and the AI-Lab Echo: A Skeptic's Field Guide

SpaceX IPO'd at $1.77T — the largest ever — then fell 20% once shorting arrived. Inside the force-fed private valuation, and why the AI labs are more exposed.

The short version

  • The “force-fed” thesis is largely correct in mechanism but overtaken by events on price. SpaceX rode a private-market valuation escalator (~$210B mid-2024 → ~$350B Dec 2024 → ~$400B July 2025 → ~$800B Dec 2025) set by twice-yearly insider tender offers, absorbed xAI in February 2026, and IPO’d on June 12, 2026 at $135/share (~$1.77T) — the largest IPO in history — popping to a ~$2T+ market cap on a thin ~4–5% float before falling ~20% once options/short-selling arrived. Public price discovery has now begun, and the most disciplined independent valuations (Damodaran $1.25–1.35T; Morningstar ~$780B / $63 a share) sit 25–55% below the IPO price. The market was force-fed; the fundamentals do not support the mark.
  • Strip away the narrative and SpaceX is two good businesses (a launch monopoly + Starlink) wrapped around a cash-incinerating AI bet. 2025 consolidated revenue was ~$18.7B (but only because xAI/X were retroactively consolidated), with a ~$4.9B net loss. Starlink is the only profitable segment (~$11.4B revenue, ~$4.4B operating profit). Launch is a genuine monopoly but small (~$4.1B). xAI lost ~$6.4B in 2025 and consumed ~$12.7B of capex. At ~$1.7T the stock trades at ~90–112x trailing sales — versus ~1.8x sales / ~16x EBITDA for Lockheed Martin. That gap is the “hopes and dreams” premium, quantified.
  • OpenAI and Anthropic are running the identical playbook and are MORE exposed to the critique, not less. Both are marked at AGI-optionality multiples (OpenAI $852B on ~$25B ARR; Anthropic $965B post-money on ~$47B run-rate) set by a tight circle of repeat backers (SoftBank, Nvidia, Amazon, a16z, GIC, Coatue) whose “circular” compute-for-equity deals inflate apparent demand. SpaceX at least owns hard assets, a launch monopoly, and a cash-gushing Starlink; the AI labs have explosive revenue growth but massive losses, unproven unit economics, and a financing structure resembling a closed loop. Honest verdict: SpaceX is overpriced but real; the AI labs are the purer expression of the force-fed phenomenon.

What stands out

SpaceX valuation trajectory — the escalator, then the launch

  • Primary rounds (small, infrequent): Series N raised $1.9B in 2020 at $46B; $850M in 2021 at $74B; $750M in January 2023 at $137B. SpaceX raised only ~$10–12B of primary equity in its entire life — striking for a company that briefly touched a ~$2T market cap.
  • Tender-offer escalator (the real price-setting mechanism): June 2024 ~$210B ($112/share); December 2024 ~$350B ($185/share; $1.25B tender of which SpaceX bought back $500M); July 2025 ~$400B ($212/share); December 2025 ~$800B ($421/share; ~$2.56B insider sale). The valuation roughly 4x’d in ~18 months on transactions that cashed out small slices of insider stock.
  • xAI merger (Feb 2, 2026): All-stock; combined entity valued ~$1.25T (SpaceX ~$1T, xAI ~$250B) — the largest private merger ever. This bolted an AI-narrative premium and a cash-burning business onto the rocket company right before the IPO.
  • IPO (June 12, 2026): 555.6M Class A shares at $135 = ~$75B raised (largest IPO ever), ~$1.77T valuation. Stock opened ~$150, ran to an all-time high of $225.64 on June 16, then fell ~20% over two sessions to ~$175–192 by June 18 once SPCX options began trading June 17 and gave bears their first practical tool. Only ~4–5% of shares were floated; ~95% locked up (first windows late July/Aug, standard lock-up ~Dec 2026, Musk’s stake to June 2027).

The fundamentals (from the S-1)

  • Consolidated revenue: 2023 ~$10.4B → 2024 ~$14.0B → 2025 ~$18.7B (+33%); Q1 2026 ~$4.7B (+15%). Critical caveat: the 33% growth is partly an artifact of common-control accounting that retroactively consolidates xAI and X into all prior periods.
  • Segment revenue 2025: Connectivity/Starlink ~$11.4B (+~50%, 61% of revenue); Space/launch ~$4.1B (+~8%); AI/xAI ~$3.2B (+22%).
  • Profitability: Consolidated net loss ~$4.9B in 2025 (vs. a ~$0.8B net profit in 2024 before xAI consolidation); adjusted EBITDA ~$6.6B. Starlink operating profit ~$4.4B (only profitable segment). Space roughly breakeven (Starship R&D ~$3B). AI operating loss ~$6.4B. Q1 2026 net loss ~$4.28B.
  • Capex: ~$20.7B in 2025 (of which ~$12.7B was AI infrastructure); Q1 2026 AI capex alone ~$7.7B (a ~$30B annualized run-rate). Free cash flow deeply negative.
  • Starlink operating metrics: Subscribers 2.3M (2023) → 4.4M (2024) → 8.9M (2025) → 10.3M (Q1 2026). But monthly ARPU fell from ~$99 (2023) → ~$91 (2024) → ~$81 (2025) → ~$66 (Q1 2026) as growth shifted to price-sensitive markets. Starlink gross margin improved 37% → 48% (2024→2025).
  • TAM claim: The prospectus headlines a $28.5T total addressable market, of which $26.5T is AI (including $22.7T of “enterprise applications”). Damodaran: “SpaceX has the largest TAM of any company in history… This estimate borders on fantasy.”
  • Governance: Dual-class. Musk holds all Class B super-voting shares and controls ~85% of votes (as-filed) / ~82% post-offering. His 2026 comp package (1 billion performance shares) vests partly on “a permanent human colony on Mars with at least one million inhabitants.”

What the multiple implies vs. comparables

  • At ~$1.7–1.8T on ~$18.7B trailing revenue, SpaceX trades at ~90–112x sales — among the highest for any large-cap in US history; MarketWatch noted it leaves “virtually zero room for error.”
  • Defense/aerospace comps trade at a fraction: Lockheed Martin ~1.8x EV/revenue, ~16x EV/EBITDA, ~17x forward P/E; Northrop Grumman ~20x forward P/E, ~15x EV/EBITDA; RTX ~17x EV/EBITDA. SpaceX trades at roughly 50x the revenue multiple of the defense primes.
  • Satellite-comms comps (Viasat, EchoStar, Eutelsat/OneWeb) trade at low-single-digit revenue multiples and ~20% EBITDA margins — far below Starlink’s reported ~50–63% EBITDA margin, which is the bull’s strongest card.

The independent valuations — the reality check

  • Aswath Damodaran (NYU “Dean of Valuation”): DCF enterprise value ~$1.22T, equity $1.3T (~$100/share). Verbatim: “At the rumored pricing of $1.8 trillion… it is too richly priced for my tastes, given my valuation of $1.25–$1.35 trillion for the equity.” His model already bakes in generous assumptions: $320B blended long-run revenue, ~50% blended operating margin, an 8.37% cost of capital, and a doubling of his AI revenue target to $160B. He still lands ~28% below the IPO price.
  • Morningstar: ~$780B / $63 a share — “overvalued,” less than half the IPO price.
  • The gap between the ~$1.7T mark and these ~$0.78–1.3T fundamentals-based estimates IS the force-fed/narrative premium. New Market Pitch’s anchor analysis pegs the “Musk effect”/narrative premium at roughly $450B–$970B (≈25–55% of the IPO valuation), midpoint ~$700B.

The fuller picture

Part 1 — The hard valuation: a monopoly, a utility, and a money pit

SpaceX is genuinely three businesses, and the first two are excellent. Launch is a near-monopoly: SpaceX flew the overwhelming majority of the world’s orbital mass in 2025, with reusable Falcon 9 economics no competitor approaches (NewStreet estimates “at least a 10-year lead”). But it is small (~$4.1B revenue, +8%), and ~66–75% of flights are internal Starlink missions that book no external revenue. Starlink is the actual value engine: a SaaS-like, recurring, high-margin utility that doubled subscribers to 10.3M and turned free-cash-flow positive in 2024. It generated ~$11.4B revenue and ~$4.4B operating profit in 2025 at an EBITDA margin reported in the 50–63% range — multiples of the ~20% margins at legacy satellite operators.

The problem is twofold. First, ARPU is falling fast — from ~$99/month (2023) to ~$66 (Q1 2026) — because incremental subscribers come from price-sensitive markets (Africa, SE Asia, LatAm). Growth is real but the unit economics are diluting, and Starlink’s revenue growth decelerated from ~95% (2024) to ~27–50% (2025, depending on source). Second, competition is finally arriving: Amazon’s Leo (formerly Kuiper) targets a mid-2026 consumer launch with claimed 1 Gbps speeds and AWS integration; Eutelsat/OneWeb revenues were up ~60% in H1; Telesat Lightspeed and others are scaling. Starlink’s lead is large but the LEO broadband market is now, in Quilty Space’s words, “a legitimate race.”

Then there is xAI — the swing factor and the skeptic’s smoking gun. Bolting xAI on in February 2026 converted a barely-profitable hardware company into a money-losing AI conglomerate. xAI lost ~$6.4B operating in 2025 on ~$3.2B revenue and consumed ~$12.7B of capex; in Q1 2026 it burned ~$7.7B of capex in a single quarter. The Colossus compute center is leased to Anthropic for ~$1.25B/month through May 2029 — an ironic arrangement where Musk’s AI lab keeps the lights on by renting GPUs to a rival. Damodaran’s central worry is precisely this: that SpaceX “will overreach in the AI business,” with Musk’s voting lock-in leaving shareholders unable to restrain capex even “after it becomes clear that the AI market is much smaller than anticipated.”

The bear case, consolidated:

  1. Valuation gap: ~$1.7T mark vs. ~$0.78–1.3T defensible DCF. The market is paying 30–120%+ over fundamentals.
  2. Government/customer concentration: ~30–40% of revenue from NASA/DoD/Space Force; lifetime federal commitments ~$22B. The June 2025 Trump–Musk feud (Trump threatening to cancel contracts; Musk threatening to decommission Dragon) showed the political tail risk is live, not theoretical.
  3. Key-man + governance risk: Musk controls ~82–85% of votes; all 11 of xAI’s original co-founders departed before the IPO; the comp package ties vesting to a Mars colony. There is no governance brake.
  4. Capex intensity & FCF: Deeply negative free cash flow; the constellation needs perpetual replenishment and the AI buildout is open-ended.
  5. Float/lock-up overhang: ~95% of stock unlocks in stages through 2027; the scarcity premium that drove the pop can reverse.
  6. No S&P 500 inclusion until four consecutive GAAP-profitable quarters (not expected before late 2027), limiting forced passive demand beyond the early-July Nasdaq-100 add.

The genuine bull case (intellectual honesty requires stating it):

  • The launch monopoly and Starlink are real, defensible, high-margin businesses with a decade-plus moat. Damodaran — no hype man — still lands at $1.3T, within shouting distance of $1.7T if you believe the AI optionality.
  • Starlink direct-to-cell (via the ~$17B EchoStar spectrum acquisition) and Starshield/defense revenue are credible, large, under-monetized adjacencies.
  • The Tesla precedent: Musk-led companies have repeatedly made “absurd” valuations look cheap in hindsight. Shorting the narrative has bankrupted smarter people than the average bear.
  • The uncertainty is arguably skewed to the upside (Damodaran’s own framing): more ways to surprise high than low if Starship’s sub-$100/kg economics unlock genuinely new markets.

Part 2 — The force-fed mechanism: how a few trades became a “market cap”

The mechanics matter more than the moralizing. Private megacap “valuations” are not market-clearing prices; they are marks set by a tiny number of insider transactions and then reported by the press as if they were market caps.

  • Tender offers as price-setting: SpaceX ran these twice a year, cashing out a small slice of employee/early-investor stock at a price negotiated between the company and a hand-picked set of “authorized buyers” — historically a tight Musk-orbit circle (a16z, Founders Fund, Gigafund, Sequoia). Musk himself noted in December 2024 that “almost no investors wanted to sell shares” at $350B — i.e., the mark was set on low volume by sellers who didn’t want to sell. The jumps (67% in six months; a doubling July→Dec 2025) were explicitly easier “because it’s easier to place small amounts of stock at aggressive valuations than large amounts.”
  • Reflexivity/circularity of marks: The same repeat funds appear round after round, and each markup increases the carrying value of their existing stake — a self-reinforcing loop where the markers benefit from the marks. The $1.5T IPO target itself was used to make the $800B December round “more palatable,” which in turn became the springboard for the IPO.
  • Secondary markets & SPVs: Forge Global, EquityZen, and Hiive let accredited investors buy slices, often through stacked SPVs with layered fees and contractual restrictions (ROFRs). Forge’s own “Forge Price” for SpaceX hit ~$1.03T by April 2026. These platforms create the appearance of liquid, tradable, priced assets while real price discovery (short-selling, mark-to-market, quarterly earnings) is absent. Forge was acquired by Schwab for $660M — down from a $2B SPAC price — a tell on how much of the “private-markets-democratization” story was itself hype.
  • Retail amplification & the premium-to-NAV absurdity: The closed-end fund Destiny Tech100 (DXYZ) is the purest illustration. Per Acadian Asset Management’s analysis, DXYZ listed on the NYSE March 26, 2024 at a $4.84 NAV and rose to $105 by April 8, 2024 — “a price that was 21X too high; the premium to NAV was more than 2,000%,” the highest CEF premium ever observed (beating the prior 1,235% record of Capital Administration Co., per DeLong & Shleifer 1991, as cited in DXYZ’s own SEC Form 497AD). Per Destiny’s Dec 31, 2025 results, NAV reached $19.97/share, “up 210% from $6.44… at the end of the fourth quarter of 2024,” on a ~$434.0M portfolio in which SpaceX was 16.2%. Morningstar called it a mechanism for retail to “enrich others at the expense of themselves.”
  • Why private marks persist where public scrutiny would not: No short-sellers, no daily mark-to-market, no quarterly earnings, illiquidity, and a powerful selection effect in who gets to transact (only insiders sell, only approved buyers buy). The result is a valuation that floats free of the disciplining forces of a public market — exactly the “force-feeding” the thesis describes. The SpaceX IPO is the natural experiment: within days of public trading and the introduction of options (the first short-selling tool), the stock fell 20% and Future Fund’s Gary Black noted it had “traded more like a meme stock than one driven by fundamentals.”

This is straight Damodaran “narrative vs. numbers”: for young companies, value is driven by TAM and unit-economics stories, not bottom lines, and the SpaceX prospectus is “a soaring story, but with weak links and multiple distractions.” The force-feeding is the propagation of the story-derived mark as if it were a fact.

Part 3 — Macro: an asset-inflation / liquidity phenomenon, late cycle

The private-megacap phenomenon is downstream of a decade-plus of cheap money. Combined PE/VC AUM went from ~$600B in 2000 to >$10T today; the 2020–21 ZIRP blow-off deployed capital at ~2x the long-run average at peak valuations. Crucially, the best companies now stay private far longer, capturing in private markets the appreciation that used to accrue to public investors — which is why a SpaceX or OpenAI can reach hundreds of billions before any public scrutiny.

The current cycle has a specific accelerant: the AI capex super-cycle. The five largest US tech spenders are guiding to ~$635–690B of 2026 capex (≈$2.1T across 2026–28), driving capex intensity to ~34% of revenue — more than double the late-1990s internet-buildout peak — and pushing aggregate free cash flow negative for the first time in ~35 years. AI investment is ~1–1.5% of GDP, comparable to past infrastructure waves but with shorter asset lives (GPUs depreciate fast).

Where are we (mid-2026)? Late, and showing classic top-signals, but not obviously broken:

  • Bear signals: index concentration into a handful of mega-caps; AI capex outrunning AI revenue with no measurable GDP impact yet; the Fed listing AI as a top systemic risk; circular financing inflating apparent demand; GMO/Hussman-style models projecting near-zero-to-negative real returns for US large-caps over 7–12 years; the Nasdaq shedding >7% from a June 1 all-time high right as SpaceX listed.
  • Bull/stabilizer signals: unlike 2000, the spenders are the most profitable companies in history, largely funding capex from cash flow (Russell 3000 capex/FCF below 1x vs. ~4x in 2000); chips sold out 18–24 months forward (real pre-paid demand); strong S&P earnings breadth.

Honest read: a liquidity-and-narrative-driven late-cycle environment in which a small number of “winner” stories absorb a disproportionate share of capital — a textbook setup for the force-fed dynamic — but one where the leaders have real cash flows, so a financing-stop bust (the dot-com pattern) is less likely than a grinding de-rating. The marginal risk is exactly that “financing stop”: if debt-funded capex (Morgan Stanley sees >$400B hyperscaler debt issuance) meets disappointing AI revenue, the reflexive loop reverses.

Part 4 — OpenAI and Anthropic: same playbook, weaker assets

OpenAI: $157B (late 2024) → $300B (March 2025 SoftBank-led $40B round) → $500B (Oct 2025 secondary) → $852B (late March 2026, after a record $122B raise at $730B pre-money anchored by SoftBank, Nvidia, Amazon). Revenue ~$13B (2025) to ~$25B annualized (Feb 2026); the $500B mark implied ~167x 2025 revenue. But it loses prodigiously: ~$8–8.5B cash burn in 2025, projected ~$27B in 2026 and ~$63B in 2027, not cash-flow positive before 2030. It carries >$1T in disclosed compute commitments (Stargate $500B, Oracle >$300B, Azure $250B, AWS ~$138B). Secondary marks reportedly reached ~$880B.

Anthropic: $61.5B (March 2025) → $183B (Sept 2025 Series F) → $380B (Feb 2026 Series G) → $965B post-money (Series H, “$65 billion… led by Altimeter Capital, Dragoneer, Greenoaks, and Sequoia Capital”). Run-rate revenue went from ~$1B (early 2025) → $9B (end-2025) → ~$14B (Feb 2026) → “crossed $47 billion earlier this month” (the Series H announcement) — among the fastest revenue ramps in software history. Backed by Amazon (~$8B+) and Google, with the now-familiar compute-for-equity structure: Anthropic committed >$100B to AWS and $30B to Azure while Amazon/Nvidia/Microsoft invest in Anthropic.

The circular-financing concern is the AI-specific version of the force-feeding mechanism. Nvidia invests up to $100B in OpenAI → OpenAI commits to buy Nvidia GPUs → routed through Oracle/CoreWeave who buy more Nvidia chips. Microsoft/Nvidia invest ~$15B in Anthropic → Anthropic spends ~$30B on their compute. The same dollar can appear as Nvidia revenue, OpenAI funding, and Oracle backlog simultaneously. As Azeem Azhar put it, a “financial ouroboros”: revenue that is “really just the same stock of money going in circles.” The February 2026 stall of the Nvidia-OpenAI deal triggered a multi-company selloff precisely because the market glimpsed how reflexive the loop is. The only number that proves real demand is revenue from outside the circle.

SpaceX vs. the AI labs — who is more “force-fed”?

DimensionSpaceXOpenAI / Anthropic
Hard assets / moatLaunch monopoly, satellite constellation — real, defensibleModel weights + brand; moat eroding (DeepSeek, open-source, price wars)
Profitable coreYes — Starlink ~$4.4B op profitNo — both burn billions
Revenue multiple~90–112x salesOpenAI ~30–167x; Anthropic ~20–40x
Cash flowDeeply negative (driven by AI bet)Deeply negative (structural)
Financing structureMostly equity + IPO cashHeavily circular compute-for-equity
Narrative anchorMars / AGI / orbital data centersAGI / “transformation of all knowledge work”

Verdict: the AI labs are MORE exposed to the force-fed critique, not less. SpaceX has a genuine, monopolistic, cash-generating core (Starlink + launch) onto which an expensive AI option has been grafted — its overvaluation is a premium-on-a-real-business problem. OpenAI and Anthropic are pure optionality plays: their entire valuations rest on capturing a multi-trillion-dollar AGI TAM that does not yet exist, financed by a circular structure that manufactures the appearance of demand. If the liquidity tide goes out, SpaceX has Starlink to fall back on; the labs have burn rates and compute commitments. The one caveat in the labs’ favor: their revenue is genuinely growing faster (Anthropic ~10x annually) than almost anything in history, so the “grow into the multiple” path is at least conceivable — whereas SpaceX’s launch and Starlink growth is decelerating and its AI growth is the slowest of the major labs.

What to watch

The picture that emerges, staged and conditional:

  1. SPCX is a flow vehicle, not a value holding, through ~Q1 2027. The stock is governed by float mechanics (4–5% float), the early-July Nasdaq-100 add (~$8–10B passive demand, but modeled at only ~1.6–2.2% price impact), and a staged lock-up — tradable, knowable catalysts. Damodaran’s framing: this is a trader’s stock right now, where intrinsic value is “perhaps even irrelevant.”

  2. The fundamental pressure window is the lock-up cascade, not now. ~95% of shares unlock in stages from late July 2026 through June 2027; the scarcity premium that drove $135→$225 can reverse hard as supply hits, with the December 2026 standard lock-up expiry the key date. The countervailing risk: this is a Musk vehicle prone to violent narrative-driven squeezes.

  3. The independent anchors, not the tape, mark fair value. Damodaran’s $1.3T (~$100–105/share split-adjusted) and Morningstar’s ~$780B ($63) bracket the corridor — value below ~$100/share, rich above ~$180–200. Thresholds that would raise fair value: Starship V3 reaching operational sub-$100/kg economics; Starlink direct-to-cell monetizing the EchoStar spectrum; Starshield/defense scaling. Thresholds that would lower it: continued ARPU erosion, an AI-capex blowout with no enterprise traction, or a renewed government-contract political rupture.

  4. For the AI labs, the signal is second-order, not in the private marks. The circular-financing loop means a financing-stop shows up first in the infrastructure layer (Nvidia, Oracle, CoreWeave debt/CDS spreads), not in illiquid OpenAI/Anthropic secondaries that cannot easily be exited. Rising infrastructure-provider CDS spreads are the early-warning system — the lenders, not just the deals.

  5. The retail-trap vehicles are structurally rigged against the buyer. DXYZ and similar premium-to-NAV closed-end funds make the premium the product. The SPV/secondary route (Forge/Hiive) at least prices closer to mark, at the cost of illiquidity and layered fees.

What would change the thesis:

  • More bullish on SPCX if: four consecutive GAAP-profitable quarters arrive (S&P 500 inclusion catalyst, ~late 2027); Starship V3 hits operational reusability and sub-$100/kg; xAI capex shows enterprise revenue traction rather than pure burn.
  • More bearish if: ARPU keeps falling while subscriber growth decelerates; Amazon Leo takes meaningful share; the AI-capex super-cycle shows a financing stop (hyperscaler capex guidance cuts, rising data-center debt spreads); or a Musk–government rupture threatens contracts.

Caveats

  • The world moved faster than the “$350B” framing this thesis started from. As of mid-2026 the live facts are: the xAI merger (Feb 2026), a $1.77T IPO (June 12, 2026), and a ~$2T peak followed by a ~20% pullback. The “force-fed at $350B+” thesis is now best understood as describing the private escalator that preceded public price discovery — and that discovery is, so far, partially vindicating the skeptics (the stock fell once shorting became possible, and independent valuations cluster 25–55% below the IPO mark).
  • Many SpaceX/xAI/Starlink figures are estimates or freshly disclosed and not yet tested under sustained public scrutiny. Segment numbers come from the S-1; pre-IPO figures relied on Quilty, Payload, Sacra, and Novaspace estimates that varied materially (2024 total revenue was variously estimated $13.1B–$14.2B). The ~33% 2025 growth is inflated by retroactive common-control consolidation of xAI/X.
  • The bull case is not trivial. Damodaran — the most credible independent skeptic — still lands at $1.3T and explicitly would not short. Musk-company valuations have repeatedly defeated fundamentals-based bears (Tesla). “Overvalued” is a statement about price relative to a probability-weighted range, not a prediction of imminent decline.
  • Source quality varies. Tender/round figures are well-corroborated (Bloomberg, CNBC, Reuters). Some secondary-market and forward-revenue figures come from interested parties (brokers, pre-IPO platforms, company press releases) and should be discounted accordingly. Forward TAM claims ($28.5T) are explicitly aspirational per the prospectus’s own disclaimers and should never be treated as established fact.